Stock PMN PROMIS NEUROSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ProMIS Neurosciences, Inc.

Equities

PMN

CA74346M4065

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
2.25 USD +6.64% Intraday chart for ProMIS Neurosciences, Inc. +25.70% +95.65%
May. 15 ProMIS Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 ProMIS Neurosciences, Inc. Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies CI

Evolution of the average Target Price on ProMIS Neurosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

886c94a4d.qDqYi8oE53KfcqcS5EIqoJ3TC2oJkG4-Wly_PBY0MBM.y2_JvL18yiLbAeJbqW9E0djgRyckqAdxGxrISEFaeD7lUd___XOqFeVG6g~677c4da73ae605725a8c64dd0fb90bb4

Analyst Recommendations on ProMIS Neurosciences, Inc.

BTIG Starts ProMIS Neurosciences With Buy Rating, Price Target is $8 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.064 CAD
Average target price
12.03 CAD
Spread / Average Target
+292.69%
High Price Target
13.05 CAD
Spread / Highest target
+326.04%
Low Price Target
11.01 CAD
Spread / Lowest Target
+259.35%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ProMIS Neurosciences, Inc.

BTIG

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PMN Stock
  4. Consensus ProMIS Neurosciences, Inc.